These 5 Stocks are Gaining Today

3. Gilead Sciences, Inc. (NASDAQ:GILD)

Number of Hedge Fund Holders: 58

Gilead Sciences, Inc. (NASDAQ:GILD) shares rose over three percent before the opening bell today after receiving an upgrade from JPMorgan. The research firm improved its ratings for the biopharmaceutical giant from “Neutral” to “Overweight.”

Analyst Chris Schott thinks improved visibility of Gilead’s HIV portfolio and its emerging oncology pipeline has yet to reflect in its stock price. Schott also lifted his price target for Gilead Sciences, Inc. (NASDAQ:GILD) from $72 per share to $80 per share.

In addition, he expects the company’s oncology business to generate sales of $5 billion by 2030. Schott also strongly believes that Gilead Sciences, Inc. (NASDAQ:GILD) shares are currently trading below their actual value.